Legal Representation
Attorney
Lance G Johnson
USPTO Deadlines
Next Deadline
2 days remaining
Published for Opposition
Due Date
January 01, 2026
Extension Available
Until February 01, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 2, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 2, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 6, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 4, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 4, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 4, 2025 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Nov 4, 2025 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Nov 4, 2025 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Nov 4, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Nov 4, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 21, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 21, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 21, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 19, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 10, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 11, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 11, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 014
Diamonds; Synthetic diamonds; Diamond jewelry
Classification
International Classes
014
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BRILLIANT"